NITI Aayog Panel to Drive AIIMS Modernization

NITI Aayog, the Indian government’s premier think tank, has established a committee to devise a roadmap for transforming AIIMS, New Delhi, into a world-class institution for medical research and healthcare excellence. Led by NITI Aayog member VK Paul, the committee will analyze current systems and propose reforms with specific timelines for their implementation. This initiative is part of a broader effort to enhance healthcare infrastructure, governance, and self-sufficiency in AIIMS.

Additionally, NITI Aayog has been working on Universal Health Coverage (UHC) and rare disease treatment affordability, partnering with CSEP Research Foundation to examine global UHC models. It has also facilitated the indigenous production of affordable drugs for rare diseases, significantly reducing treatment costs.

Key Highlights of AIIMS Transformation Panel

Committee Formation

  • Led by VK Paul, focusing on AIIMS New Delhi’s transformation.

Objectives

  • Assess current systems & propose reforms with clear timelines.
  • Improve patient inflow management and hospital governance.
  • Develop Key Performance Indicators (KPIs) for clinical, academic, and research excellence.
  • Enhance financial prudence & sustainability in AIIMS operations.

Focus Areas

  • Governance & transparency.
  • Research excellence.
  • Clinical & academic improvements.
  • Self-sufficiency & financial sustainability.

NITI Aayog’s Efforts on Universal Health Coverage (UHC)

  • Partnership with CSEP Research Foundation to study global UHC models.

Draft paper on healthcare financing strategies,

  • Addresses supply-side & demand-side financing.
  • Aims to improve healthcare accessibility, quality, and affordability.
  • Extensive government & stakeholder consultations planned to shape policies.

Rare Disease Drug Accessibility Initiative

  • Effort to provide affordable indigenous treatments for rare diseases.
  • 4 affordable drugs introduced, priced at 1/60th to 1/100th of imported versions.
  • 4 more drugs undergoing regulatory approval, expected to launch by year-end.
Summary/Static Details
Why in the news? NITI Aayog Panel to Drive AIIMS Modernization
AIIMS Transformation Panel Committee led by VK Paul to improve AIIMS systems, governance, and sustainability.
Key Focus Areas Patient inflow, KPIs, governance, financial sustainability, transparency.
Universal Health Coverage (UHC) Study NITI Aayog & CSEP Research Foundation examining global UHC models.
Healthcare Financing Reforms Addresses supply & demand-side financing to improve accessibility & affordability.
Affordable Rare Disease Drugs 4 drugs introduced at 1/60th to 1/100th of imported costs, 4 more in pipeline.
Shivam

Recent Posts

Thailand’s Opal Suchata Chuangsri Crowned Miss World 2025 in Hyderabad

Thailand’s Opal Suchata Chuangsri was crowned Miss World 2025. The grand finale took place on…

11 hours ago

Valmik Thapar, Who Spent 50 years with Tigers, Passes Away at 73

Valmik Thapar, a famous wildlife and tiger conservationist, passed away in Delhi on May 31,…

1 day ago

Rashtriya Boudhik Sampada Mahotsav-2025 at CSIR-IIP, Dehradun

CSIR-Indian Institute of Petroleum (CSIR-IIP), Dehradun celebrated Rashtriya Boudhik Sampada Mahotsav (RBSM) 2025 on 29th…

1 day ago

Mary Earps Retires from International Football

Mary Earps, one of England's top football goalkeepers, has decided to retire from International football.…

1 day ago

CBI’s Arrest Six Members of Cybercrime

The Central Bureau of Investigation (CBI) has arrested six people involved in a large cybercrime…

2 days ago

IPL 2025: Rohit Sharma Becomes First Indian Batter to Smash 300 Sixes

Rohit Sharma, one of the most prolific and celebrated batters in Indian Premier League (IPL)…

2 days ago